SCIENION opens French subsidiary Cellenion with focus on controlled cell dispensing technologies

13-Oct-2016 - Germany

SCIENION AG, a provider for ultra-low volume liquid handling applications, announced that its new subsidiary Cellenion S.A.S. started operations in Lyon, France back in May 2016. Cellenion focuses on controlled cell dispensing technologies in the fields of bioprinting and single-cell dispensing.

R&D-focused Cellenion will specialize on two main topics of investigation, bioprinting and single-cell dispensing.

While accurate single-cell dispensing offers new opportunities for single-cell analytics and the development of novel cell lines, bioprinting allows for generating spatially controlled cell patterns using 3D printing technologies. This is a hot topic in various applications, for example to develop better screening assays for the pharmaceutical industry. Cell-based 3D models of human origin will provide a better representation of real tissues and overcome limitations of conventional monolayer assays, which are known to lack the functionalities of real tissues. Cellenion is also engaged in developing reproducible skin models. Validated skin models already replace animal testing and are of utmost interest to the cosmetic industry. Cellenion aims towards miniaturization and automation in order to produce reproducible models of different complexities. Recently, Cellenion became a member of the Lyon-based European Centre of Dermocosmetology to promote interdisciplinary research projects in this field.

Future objectives include the generation of organoids up to complete organs and Cellenion is board member of CellSpace, an association dedicated to the research on tissue and organ construction by bioengineering.

“We already have a proven track record in cell dispensing applications”, says Holger Eickhoff, CEO of SCIENION AG. “With our new venture in France we are bundling forces to accelerate the development in this exiting field. With SCIENION’s outstanding dispensing technologies and expertise, Cellenion is virtually predestined to become a leading player in bioprinting and cell dispensing technologies.”

https://www.bionity.com/en/news/160101/scienion-opens-french-subsidiary-cellenion-with-focus-on-controlled-cell-dispensing-technologies.html